TEST BANK @zx
Pharmacotherapeutics for Advanced Practice: A Practical Approach
@zx @zx @zx @zx @zx @zx
by Virginia Poole Arcangelo, Andrew M. Peterson Fifth EDITION.
@zx @zx @zx @zx @zx @zx @zx @zx
FULL TEST BANK!!! @zx @zx
,Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
ANS: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
ANS: A PTS: 1
, lOMoAR
@zx
SD|
cP
@zx
07614
210
Chapter 2.Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
@zx @zx @zx @zx @zx @zx
MULTIPLE @zxCHOICE
1. A @zxpatient's @zxnutritional @zxintake @zxand @zxlab @zxwork @zxreflects @zxhypoalbuminemia.
This @zxis @zxcritical @zxto @zxprescribing @zxbecause:
@zx
A. Distribution @zxof @zxdrugs @zxto @zxtarget @zxtissue @zxmay @zxbe @zxaffected
B. The @zxsolubility @zxof @zxthe @zxdrug @zxwill @zxnot @zxmatch @zxthe @zxsite @zxof @zxabsorption
C. There @zxwill @zxbe @zxless @zxfree @zxdrug @zxavailable @zxto @zxgenerate @zxan @zxeffect
D. Drugs @zxbound @zxto @zxalbumin @zxare @zxreadily @zxexcreted @zxby @zxthe @zxkidney
ANS: @ z x A PTS: @ z x 1
2. Drugs @zxthat @zxhave @zxa @zxsignificant @zxfirst-pass @zxeffect:
A. Must @zxbe @zxgiven @zxby @zxthe @zxenteral @zx(oral) @zxroute @zxonly
B. Bypass @zxthe @zxhepatic @zxcirculation
C. Are @zxrapidly @zxmetabolized @zxby @zxthe @zxliver @zxand @zxmay @zxhave @zxlittle @zxif @zxany @zxdesired
@zx action
D. Are @zxconverted @zxby @zxthe @zxliver @zxto @zxmore @zxactive @zxand @zxfat-soluble @zxforms
ANS: @ z x C PTS: @ z x 1
3. The @zxroute @zxof @zxexcretion @zxof @zxa @zxvolatile @zxdrug @zxwill @zxlikely @zxbe:
A. The @zxkidneys
B. The @zxlungs
C. The @zxbile @zxand @zxfeces
D. The @zxskin
ANS: @ z x B PTS: @ z x 1
4. Medroxyprogesterone @zx(Depo @zxProvera) @zxis @zxprescribed @zxIM @zxto @zxcreate @zxa @zxstorage
reservoir @zxof @zxthe @zxdrug. @zxStorage @zxreservoirs:
@zx
A. Assure @zxthat @zxthe @zxdrug @zxwill @zxreach @zxits @zxintended @zxtarget @zxtissue
B. Are @zxthe @zxreason @zxfor @zxgiving @zxloading @zxdoses
C. Increase @zxthe @zxlength @zxof @zxtime @zxa @zxdrug @zxis @zxavailable @zxand @zxactive
D. Are @zxmost @zxcommon @zxin @zxcollagen @zxtissues
ANS: @ z x C PTS: @ z x 1
5. The @zxNP @zxchooses @zxto @zxgive @zxcephalexin @zxevery @zx8 @zxhours @zxbased @zxon @zxknowledge @zxof
@zx the @zxdrug's:
A. Propensity @zxto @zxgo @zxto @zxthe @zxtarget @zxreceptor
B. Biological @zxhalf-life
C. Pharmacodynamics
D. Safety @zxand @zxside @zxeffects
ANS: @ z x B PTS: @ z x 1
6. Azithromycin @zxdosing @zxrequires @zxthe @zxfirst @zxday's @zxdose @zxbe @zxtwice @zxthose @zxof @zxthe
@zxother @zx4 @zxdays @zxof @zxthe @zxprescription. @zxThis @zxis @zxconsidered @zxa @zxloading @zxdose. @zxA
@zxloading @zxdose:
A. Rapidly @zxachieves @zxdrug @zxlevels @zxin @zxthe @zxtherapeutic @zxrange
B. Requires @zxfour @zxto @zxfive @zxhalf-lives @zxto @zxattain
C. Is @zxinfluenced @zxby @zxrenal @zxfunction
, lOMoAR
@zx
SD|
cP
@zx
07614
210
D. Is @zxdirectly @zxrelated @zxto @zxthe @zxdrug @zxcirculating @zxto @zxthe @zxtarget @zxtissues
ANS: @ z x A PTS: @ z x @zx 1
7. The @zxpoint @zxin @zxtime @zxon @zxthe @zxdrug @zxconcentration @zxcurve @zxthat @zxindicates @zxthe @zxfirst
sign @zxof @zxa @zxtherapeutic @zxeffect @zxis @zxthe:
@zx
A. Minimum @zxadverse @zxeffect @zxlevel
B. Peak @zxof @zxaction
C. Onset @zxof @zxaction
D. Therapeutic @zxrange
ANS: @ z x C PTS: @ z x 1
8. Phenytoin @zxrequires @zxa @zxtrough @zxlevel @zxbe @zxdrawn. @zxPeak @zxand @zxtrough @zxlevels @zxare @zxdone:
A. When @zxthe @zxdrug @zxhas @zxa @zxwide @zxtherapeutic @zxrange
B. When @zxthe @zxdrug @zxwill @zxbe @zxadministered @zxfor @zxa @zxshort @zxtime @zxonly
C. When @zxthere @zxis @zxa @zxhigh @zxcorrelation @zxbetween @zxthe @zxdose @zxand @zxsaturation @zxof
receptor @zxsites
@zx
D. To @zxdetermine @zxif @zxa @zxdrug @zxis @zxin @zxthe @zxtherapeutic @zxrange
ANS: @ z x D PTS: @ z x 1
9. A @zxlaboratory @zxresult @zxindicates @zxthe @zxpeak @zxlevel @zxfor @zxa @zxdrug @zxis @zxabove
the @zxminimum @zxtoxic @zxconcentration. @zxThis @zxmeans @zxthat @zxthe:
@zx
A. Concentration @zxwill @zxproduce @zxtherapeutic @zxeffects
B. Concentration @zxwill @zxproduce @zxan @zxadverse @zxresponse
C. Time @zxbetween @zxdoses @zxmust @zxbe @zxshortened
D. Duration @zxof @zxaction @zxof @zxthe @zxdrug @zxis @zxtoo @zxlong
ANS: @ z x B PTS: @ z x 1
10. Drugs @zxthat @zxare @zxreceptor @zxagonists @zxmay @zxdemonstrate @zxwhat @zxproperty?
A. Irreversible @zxbinding @zxto @zxthe @zxdrug @zxreceptor @zxsite
B. Up-regulation @zxwith @zxchronic @zxuse
C. Desensitization @zxor @zxdown-regulation @zxwith @zxcontinuous @zxuse
D. Inverse @zxrelationship @zxbetween @zxdrug @zxconcentration @zxand @zxdrug @zxaction
ANS: @ z x C PTS: @ z x 1
11. Drugs @zxthat @zxare @zxreceptor @zxantagonists, @zxsuch @zxas @zxbeta @zxblockers, @zxmay @zxcause:
A. Down-regulation @zxof @zxthe @zxdrug @zxreceptor
B. An @zxexaggerated @zxresponse @zxif @zxabruptly @zxdiscontinued
C. Partial @zxblockade @zxof @zxthe @zxeffects @zxof @zxagonist @zxdrugs
D. An @zxexaggerated @zxresponse @zxto @zxcompetitive @zxdrug @zxagonists
ANS: @ z x B PTS: @ z x 1
12. Factors @zxthat @zxaffect @zxgastric @zxdrug @zxabsorption @zxinclude:
A. Liver @zxenzyme @zxactivity
B. Protein-binding @zxproperties @zxof @zxthe @zxdrug @zxmolecule
C. Lipid @zxsolubility @zxof @zxthe @zxdrug
D. Ability @zxto @zxchew @zxand @zxswallow
ANS: @ z x C PTS: @ z x 1
WWW.TEGTBANKTANK.COM
Pharmacotherapeutics for Advanced Practice: A Practical Approach
@zx @zx @zx @zx @zx @zx
by Virginia Poole Arcangelo, Andrew M. Peterson Fifth EDITION.
@zx @zx @zx @zx @zx @zx @zx @zx
FULL TEST BANK!!! @zx @zx
,Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
ANS: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
ANS: A PTS: 1
, lOMoAR
@zx
SD|
cP
@zx
07614
210
Chapter 2.Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
@zx @zx @zx @zx @zx @zx
MULTIPLE @zxCHOICE
1. A @zxpatient's @zxnutritional @zxintake @zxand @zxlab @zxwork @zxreflects @zxhypoalbuminemia.
This @zxis @zxcritical @zxto @zxprescribing @zxbecause:
@zx
A. Distribution @zxof @zxdrugs @zxto @zxtarget @zxtissue @zxmay @zxbe @zxaffected
B. The @zxsolubility @zxof @zxthe @zxdrug @zxwill @zxnot @zxmatch @zxthe @zxsite @zxof @zxabsorption
C. There @zxwill @zxbe @zxless @zxfree @zxdrug @zxavailable @zxto @zxgenerate @zxan @zxeffect
D. Drugs @zxbound @zxto @zxalbumin @zxare @zxreadily @zxexcreted @zxby @zxthe @zxkidney
ANS: @ z x A PTS: @ z x 1
2. Drugs @zxthat @zxhave @zxa @zxsignificant @zxfirst-pass @zxeffect:
A. Must @zxbe @zxgiven @zxby @zxthe @zxenteral @zx(oral) @zxroute @zxonly
B. Bypass @zxthe @zxhepatic @zxcirculation
C. Are @zxrapidly @zxmetabolized @zxby @zxthe @zxliver @zxand @zxmay @zxhave @zxlittle @zxif @zxany @zxdesired
@zx action
D. Are @zxconverted @zxby @zxthe @zxliver @zxto @zxmore @zxactive @zxand @zxfat-soluble @zxforms
ANS: @ z x C PTS: @ z x 1
3. The @zxroute @zxof @zxexcretion @zxof @zxa @zxvolatile @zxdrug @zxwill @zxlikely @zxbe:
A. The @zxkidneys
B. The @zxlungs
C. The @zxbile @zxand @zxfeces
D. The @zxskin
ANS: @ z x B PTS: @ z x 1
4. Medroxyprogesterone @zx(Depo @zxProvera) @zxis @zxprescribed @zxIM @zxto @zxcreate @zxa @zxstorage
reservoir @zxof @zxthe @zxdrug. @zxStorage @zxreservoirs:
@zx
A. Assure @zxthat @zxthe @zxdrug @zxwill @zxreach @zxits @zxintended @zxtarget @zxtissue
B. Are @zxthe @zxreason @zxfor @zxgiving @zxloading @zxdoses
C. Increase @zxthe @zxlength @zxof @zxtime @zxa @zxdrug @zxis @zxavailable @zxand @zxactive
D. Are @zxmost @zxcommon @zxin @zxcollagen @zxtissues
ANS: @ z x C PTS: @ z x 1
5. The @zxNP @zxchooses @zxto @zxgive @zxcephalexin @zxevery @zx8 @zxhours @zxbased @zxon @zxknowledge @zxof
@zx the @zxdrug's:
A. Propensity @zxto @zxgo @zxto @zxthe @zxtarget @zxreceptor
B. Biological @zxhalf-life
C. Pharmacodynamics
D. Safety @zxand @zxside @zxeffects
ANS: @ z x B PTS: @ z x 1
6. Azithromycin @zxdosing @zxrequires @zxthe @zxfirst @zxday's @zxdose @zxbe @zxtwice @zxthose @zxof @zxthe
@zxother @zx4 @zxdays @zxof @zxthe @zxprescription. @zxThis @zxis @zxconsidered @zxa @zxloading @zxdose. @zxA
@zxloading @zxdose:
A. Rapidly @zxachieves @zxdrug @zxlevels @zxin @zxthe @zxtherapeutic @zxrange
B. Requires @zxfour @zxto @zxfive @zxhalf-lives @zxto @zxattain
C. Is @zxinfluenced @zxby @zxrenal @zxfunction
, lOMoAR
@zx
SD|
cP
@zx
07614
210
D. Is @zxdirectly @zxrelated @zxto @zxthe @zxdrug @zxcirculating @zxto @zxthe @zxtarget @zxtissues
ANS: @ z x A PTS: @ z x @zx 1
7. The @zxpoint @zxin @zxtime @zxon @zxthe @zxdrug @zxconcentration @zxcurve @zxthat @zxindicates @zxthe @zxfirst
sign @zxof @zxa @zxtherapeutic @zxeffect @zxis @zxthe:
@zx
A. Minimum @zxadverse @zxeffect @zxlevel
B. Peak @zxof @zxaction
C. Onset @zxof @zxaction
D. Therapeutic @zxrange
ANS: @ z x C PTS: @ z x 1
8. Phenytoin @zxrequires @zxa @zxtrough @zxlevel @zxbe @zxdrawn. @zxPeak @zxand @zxtrough @zxlevels @zxare @zxdone:
A. When @zxthe @zxdrug @zxhas @zxa @zxwide @zxtherapeutic @zxrange
B. When @zxthe @zxdrug @zxwill @zxbe @zxadministered @zxfor @zxa @zxshort @zxtime @zxonly
C. When @zxthere @zxis @zxa @zxhigh @zxcorrelation @zxbetween @zxthe @zxdose @zxand @zxsaturation @zxof
receptor @zxsites
@zx
D. To @zxdetermine @zxif @zxa @zxdrug @zxis @zxin @zxthe @zxtherapeutic @zxrange
ANS: @ z x D PTS: @ z x 1
9. A @zxlaboratory @zxresult @zxindicates @zxthe @zxpeak @zxlevel @zxfor @zxa @zxdrug @zxis @zxabove
the @zxminimum @zxtoxic @zxconcentration. @zxThis @zxmeans @zxthat @zxthe:
@zx
A. Concentration @zxwill @zxproduce @zxtherapeutic @zxeffects
B. Concentration @zxwill @zxproduce @zxan @zxadverse @zxresponse
C. Time @zxbetween @zxdoses @zxmust @zxbe @zxshortened
D. Duration @zxof @zxaction @zxof @zxthe @zxdrug @zxis @zxtoo @zxlong
ANS: @ z x B PTS: @ z x 1
10. Drugs @zxthat @zxare @zxreceptor @zxagonists @zxmay @zxdemonstrate @zxwhat @zxproperty?
A. Irreversible @zxbinding @zxto @zxthe @zxdrug @zxreceptor @zxsite
B. Up-regulation @zxwith @zxchronic @zxuse
C. Desensitization @zxor @zxdown-regulation @zxwith @zxcontinuous @zxuse
D. Inverse @zxrelationship @zxbetween @zxdrug @zxconcentration @zxand @zxdrug @zxaction
ANS: @ z x C PTS: @ z x 1
11. Drugs @zxthat @zxare @zxreceptor @zxantagonists, @zxsuch @zxas @zxbeta @zxblockers, @zxmay @zxcause:
A. Down-regulation @zxof @zxthe @zxdrug @zxreceptor
B. An @zxexaggerated @zxresponse @zxif @zxabruptly @zxdiscontinued
C. Partial @zxblockade @zxof @zxthe @zxeffects @zxof @zxagonist @zxdrugs
D. An @zxexaggerated @zxresponse @zxto @zxcompetitive @zxdrug @zxagonists
ANS: @ z x B PTS: @ z x 1
12. Factors @zxthat @zxaffect @zxgastric @zxdrug @zxabsorption @zxinclude:
A. Liver @zxenzyme @zxactivity
B. Protein-binding @zxproperties @zxof @zxthe @zxdrug @zxmolecule
C. Lipid @zxsolubility @zxof @zxthe @zxdrug
D. Ability @zxto @zxchew @zxand @zxswallow
ANS: @ z x C PTS: @ z x 1
WWW.TEGTBANKTANK.COM
